Therapeutic Potential of Hydrogen-Rich Water on Muscle Atrophy Caused by Immobilization in a Mouse Model
-
Published:2023-10-10
Issue:10
Volume:16
Page:1436
-
ISSN:1424-8247
-
Container-title:Pharmaceuticals
-
language:en
-
Short-container-title:Pharmaceuticals
Author:
Nazari Seyedeh Elnaz1, Tarnava Alex2ORCID, Khalili-Tanha Nima1, Darroudi Mahdieh1ORCID, Khalili-Tanha Ghazaleh1, Avan Amir1ORCID, Khazaei Majid1, LeBaron Tyler W.34ORCID
Affiliation:
1. Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad 13131-99137, Iran 2. Drink HRW, New Westminster, BC V3J 0B6, Canada 3. Department of Kinesiology and Outdoor Recreation, Southern Utah University, Cedar City, UT 84720, USA 4. Molecular Hydrogen Institute, Enoch, UT 84721, USA
Abstract
Skeletal muscle atrophy is associated with poor quality of life and disability. Thus, finding a new strategy for the prevention and treatment of skeletal muscle atrophy is very crucial. This study aimed to investigate the therapeutic potential of hydrogen-rich water (HRW) on muscle atrophy in a unilateral hind limb immobilization model. Thirty-six male Balb/C mice were divided into control (without immobilization), atrophy, and atrophy + hydrogen-rich water (HRW). Unilateral hind limb immobilization was induced using a splint for 7 days (atrophy) and removed for 10 days (recovery). At the end of each phase, gastrocnemius and soleus muscle weight, limb grip strength, skeletal muscle histopathology, muscle fiber size, cross-section area (CSA), serum troponin I and skeletal muscle IL-6, TNF-α and Malondialdehyde (MDA), and mRNA expression of NF-κB, BAX and Beclin-1 were evaluated. Muscle weight and limb grip strength in the H2-treated group were significantly improved during the atrophy phase, and this improvement continued during the recovery period. Treatment by HRW increased CSA and muscle fiber size and reduced muscle fibrosis, serum troponin I, IL-6, TNF-α and MDA which was more prominent in the atrophy phase. These data suggest that HRW could improve muscle atrophy in an immobilized condition and could be considered a new strategy during rehabilitation.
Funder
Mashhad University of Medical Sciences DrinkHRW
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference46 articles.
1. Disuse-induced muscle wasting;Bodine;Int. J. Biochem. Cell Biol.,2013 2. Muscle wasting in disease: Molecular mechanisms and promising therapies;Cohen;Nat. Rev. Drug Discov.,2015 3. Huang, L., Li, M., Deng, C., Qiu, J., Wang, K., Chang, M., Zhou, S., Gu, Y., Shen, Y., and Wang, W. (2022). Potential Therapeutic Strategies for Skeletal Muscle Atrophy. Antioxidants, 12. 4. Oxidative stress and disuse muscle atrophy;Powers;J. Appl. Physiol. (1985),2007 5. Oxidative stress in skeletal muscle atrophied by immobilization;Kondo;Acta Physiol. Scand.,1991
|
|